Erythropoiesis: insights from a genomic perspective

참고문헌 (100)

1. Palis, J., "Development of ery throid and myeloid progenitors in the yolk sac and embryo proper of the mouse", Development, 126, pp.5073~5084 (1999)
2. Dzierzak, E., "Erythropoiesis : development and differentiation", Cold Spring Harb. Perspect. Med, 3, pp.a011601~ (2013)
3. Orkin, S. H., "Hematopoiesis : an evolving paradigm for stem cell biology", Cell, 132, pp.631~644 (2008)
4. Giarratana, M. C., "Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells", Nat. Biotechnol, 23, pp.69~74 (2005)
5. Neildez-Nguyen, T. M. A., "Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo", Nat. Biotechnol, 20, pp.467~472 (2002)
6. Klein, E., "Properties of the K562 cell line derived from a patient with chronic myeloid leukemia", Int. J. Cancer, 19, pp.136~ (1977)
7. Tsiftsoglou, A. S., "Differentiation of leukemic cell lines : a review focusing on murine erythroleukemia and human hl-60 cells", Int. J. Cell Cloning, 3, pp.349~366 (1985)
8. Weiss, M. J., "Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line", Mol. Cell. Biol, 17, pp.1642~1651 (1997)
9. Tsang, A. P., "FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation", Cell, 90, pp.109~119 (1997)
10. Pishesha, N., "Transcriptional divergence and conservation of human and mouse erythropoiesis", Proc. Natl. Acad. Sci. USA, 111, pp.4103~4108 (2014)
11. Sankaran, V. G., "Developmental and species-divergent globin switching are driven by BCL11A", Nature, 460, pp.1093~1097 (2009)
12. Tsai, S. F., "Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells", Nature, 339, pp.446~451 (1989)
13. Evans, T., "The erythroid-specific transcription factor Eryf1 : a new f inger protein", Cell, 58, pp.877~885 (1989)
14. Orkin, S. H., "GATA-binding transcript ion factors in hematopoietic cells", Blood, 80, pp.575~581 (2019)
15. Steiner, L. A., "Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genes", Mol. Cell. Biol, 29, pp.5399~5412 (2009)
16. Martin, D. I. K., "Transcriptional activation and DNA binding by the erythroid factor GF-1", NF-E1, Genes Dev, pp.1990, 4[DOI]
17. Briegel, K., "Regulation and function of transcription factor GATA-1 during red blood cell differentiation", Development, 122, pp.3839~3850 (1996)
18. Tanimura, N., "Mechanism governing heme synthesis reveals a GATA factor", heme circuit that controls differentiation, 2016, pp.17, 249~265
19. Cheng, Y., "Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression", Genome Res, 19, pp.2172~2184 (2009)
20. Cantor, A. B., "Coregulation of GATA factors by the Friend of GATA(FOG)family of multitype zinc finger proteins", Semin. Cell Dev. Biol, 16, pp.117~128 (2005)
21. Fujiwara, Y., "Arrested devel opment of embryonic red cell precursors in mouse embryos lacking transcrip tion factor GATA-1", Proc. Natl. Acad. Sci. USA, 93, pp.12355~12358 (1996)
22. Stachura, D. L., "Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1", Blood, 107, pp.87~97 (2006)
23. Lowry, J. A., "GATA-1 : one protein, many partners", Int. J. Biochem. Cell Biol, 38, pp.6~11 (2006)
24. Morceau, F., "GATA-1 : Friends, brothers, and coworkers", Ann. NY. Acad. Sci, 1030, pp.537~554 (2004)
25. Porcher, C., "The T cell leukemia oncoprotein SCL", tal-1 is essential for development of all hematopoietic lineages, 1996, pp.86, 47~57
26. Robb, L., "The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse", EMBO J, 15, pp.4123~4129 (1996)
27. Porcher, C., "SCL", TAL1 : a multifaceted regulator from blood development to disease, 2017, pp.129, 2051~2060
28. Palii, C. G., "Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages", EMBO J, 30, pp.494~509 (2011)
29. Finger, L. R., "Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma", Proc. Natl. Acad. Sci. USA, 86, pp.5039~5043 (1989)
30. Sanda, T., "Core transcriptional regulatory circuit controlled by the TAL1complex in human T cell acute lymphoblastic leukemia", Cancer Cell, 22, pp.209~221 (2012)
31. Malyavantham, K. S., "Identifying functional neighborhoods within the cell nucleus : proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1γ, matrin 3 and SAF-A", J. Cell. Biochem, 105, pp.391~403 (2008)
32. Borg, J., "Haploinsufficiency for the erythroid transcription factor KLF1causes hereditary persistence of fetal hemoglobin", Nat. Genet, 42, pp.801~807 (2010)
33. Perkins, A. C., "Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF", Nature, 25, pp.318~322 (1995)
34. Nuez, B., "Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene", Nature, 375, pp.316~318 (1995)
35. Waye, J. S., "Krüppel-like factor 1 : hematologic phenotypes associated with KLF1 gene mutations", Int. J. Lab. Hematol, 37, pp.78~84 (2015)
36. Pilon, A. M., "Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2", Mol. Cell. Biol, 28, pp.7394~7401 (2008)
37. Tallack, M. R., "EKLF", KLF1 controls cell cycle entry via direct regulation of E2f2, 2009, pp.284, 20966~20974
38. Soza-Ried, C., "Essential role of c-myb in definitive hematopoiesis is evolutionarily conserved", Proc. Natl. Acad. Sci. USA, 107, pp.17304~17308 (2010)
39. Oh, I. H., "The myb gene family in cell growth, differentiation and apoptosis", Oncogene, 18, pp.3017~3033 (1999)
40. Greig, K. T., "Critical roles for c-Myb in hematopoietic progenitor cells", Semin. Immunol, 20, pp.247~256 (2008)
41. Davidson, C. J., "Functional evolution of the vertebrate Myb gene family : B-Myb, but neither A-Myb nor c Myb, complements drosophila Myb in hemocytes", Genetics, 169, pp.215~229 (2005)
42. Wang, X., "MYB—A regulatory factor in hematopoiesis", Gene, 665, pp.6~17 (2018)
43. Mucenski, M. L., "A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis", Cell, 65, pp.677~689 (1991)
44. Gewirtz, A. M., "A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro", Science, 242, pp.1303~1306 (1988)
45. Vegiopoulos, A., "Coordination of erythropoiesis by the transcription factor c-Myb", Blood, 107, pp.4703~4710 (2006)
46. Emambokus, N., "Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb", EMBO J, 22, pp.4478~4488 (2003)
47. Selvakumaran, M., "Deregulated c-myb disrupts interleukin-6-or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc : role in leukemogenesis", Mol. Cell. Biol, 12, pp.2493~2500 (1992)
48. Hanscombe, O., "Importance of globin gene order for correct develop mental expression", Genes Dev, 5, pp.1387~1394 (1991)
49. A. stamatoyannopoulos, J., "NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human β-globin locus control region", EMBO J, 14, pp.106~116 (1995)
50. Elnitski, L., "Conserved E boxes function as part of the enhancer in hypersensitive site 2 of the β-globin locus control region : role of basic helix–loop–helix proteins", J. Biol. Chem, 272, pp.369~378 (1997)
51. Liang, S., "Locus control region mediated regulation of adult β-globin gene expression", J. Cell. Biochem, 105, pp.9~16 (2008)
52. Smith, Z. D., "DNA methylation: roles in mammalian development", Nat. Rev. Genet, 14, pp.204~220 (2013)
53. Greenberg, M. V. C., "The diverse roles of DNA methylation in mammalian development and disease", Nat. Rev. Mol. Cell Biol, 20, pp.590~607 (2019)
54. Ji, H., "Comprehensive methylome map of lineage commitment from haematopoietic progenitors", Nature, 467, pp.338~342 (2010)
55. Bock, C., "DNA methylation dynamics during in vivo differentiation of blood and skin stem cells", Mol. Cell, 47, pp.633~647 (2012)
56. Tagoh, H., "Dynamic reorganization of chromatin structure and selective DNA demethylation prior to stable enhancer complex formation during differ entiation of primary hematopoietic cells in vitro", Blood, 103, pp.2950~2955 (2004)
57. Ginder, G. D., "The role of the epigenetic signal, DNA methylation, in gene regulation during erythroid development", Curr. Top. Dev. Biol, 82, pp.85~116 (2008)
58. Lessard, S., "Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors", Gen ome Med, 7, pp.1~12 (2015)
59. Bartholdy, B., "Mechanisms of establishment and functional significance of DNA demethylation during erythroid differentiation", Blood Adv, 2, pp.1833~1852 (2018)
60. Izzo, F., "DNA methylation disruption reshapes the hematopoietic differ entiation landscape", Nat. Genet, 52, pp.378~387 (2020)
61. Yang, L., "DNMT3A loss drives enhancer hypomethylation in FLT3-ITD associated leukemias", Cancer Cell, 29, pp.922~934 (2016)
62. DeVilbiss, A. W., "Epigenetic determinants of erythropoiesis : role of the histone methyltransferase SetD8 in promoting erythroid cell maturation and survival", Mol. Cell. Biol, 35, pp.2073~2087 (2015)
63. Rice, K. L., "Epigenetic regulation of normal and malignant hematopoiesis", Oncogene, 26, pp.6697~6714 (2007)
64. Hattangadi, S. M., "From stem cell to red cell : regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications", Blood, 118, pp.6258~6268 (2011)
65. Sun, X. J., "The role of histone acetyl transferases in normal and malignant hematopoiesis", Front. Oncol, 5, pp.1~11 (2015)
66. Wang, Y., "Impairment of human terminal erythroid differentiation by his tone deacetylase 5 deficiency", Blood, 138, pp.1615~1627 (2021)
67. Feng, Y., "Early mammalian erythropoiesis requires the Dot1L methyl transferase", Blood, 116, pp.4483~4491 (2010)
68. Mei, Y., "Understanding terminal erythropoiesis : An update on chromatin condensation, enucleation, and reticulocyte maturation", Blood Rev, 46, pp.100740~ (2021)
69. Li, M., "Stage-specific dual function : EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation", Haematologica, 108, pp.2487~2502 (2023)
70. Bultman, S. J., "A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI", SNF-related complexes in β-globin expression and erythroid development, 2005, pp.19, 2849~2861
71. Zhang, W., "Site-specific acetylation by p300 or CREB binding protein regulates erythroid Krüppel-like factor tran scriptional activity via its interaction with the SWI–SNF complex", Mol. Cell. Biol, 21, pp.2413~2422 (2001)
72. Peterson, C. L., "Promoter targeting and chromatin remodeling by the SWI", SNF complex, 2000, pp.10, 187~192
73. Xu, Z., "Recruitment of the SWI", SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors, 2006, pp.399, 297~304
74. Miccio, A., "NuRD mediates activating and repressive functions of GATA-1and FOG-1 during blood development", EMBO J, 29, pp.442~456 (2010)
75. Gregory, G. D., "FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment", Blood, 115, pp.2156~2166 (2010)
76. Gao, Z., "FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis", EMBO J, 29, pp.457~468 (2010)
77. Cha, H. J., "Inner nuclear protein Matrin-3 coordinates cell differentiation by stabilizing chromatin architecture", Nat. Commun, 12, pp.6241~ (2021)
78. Da Costa, L., "Diamond-Blackfan anemia", Blood, 136, pp.1262~1273 (2020)
79. Flygare, J., "Diamond–Blackfan anemia : erythropoiesis lost in translation", Blood, 109, pp.3152~3160 (2007)
80. Oikonomidou, P. R., "What can we learn from ineffective ery thropoiesis in thalassemia?", Blood Rev, 32, pp.130~143 (2018)
81. Ribeil, J. A., "Ineffective erythropoiesis in β-thalassemia", Sci. World J, 2013, pp.394295~ (2013)
82. Pelcovits, A., "Acute myeloid leukemia: a review", R. I. Med. J, 103, pp.38~40 (2013)
83. Porwit, A., "Acute myeloid leukemia with expanded ery thropoiesis", Haematologica, 96, pp.1241~1243 (2011)
84. Stone, R. M., "Acute myeloid leukemia", Hematol. Am. Soc. Hematol. Educ. Program, 1, pp.98~117 (2004)
85. Zuo, Z., "Acute erythroid leukemia", Arch. Pathol. Lab. Med, 134, pp.1261~1270 (2010)
86. Boddu, P., "Erythroleukemia-historical perspectives and recent advances in diagnosis and management", Blood Rev, 32, pp.96~105 (2018)
87. Challen, G. A., "Clonal hematopoiesis : mechanisms driving dominance of stem cell clones", Blood, 136, pp.1590~1598 (2020)
88. Steensma, D. P., "Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes", Blood, 126, pp.9~16 (2015)
89. Steensma, D. P., "Does clonal hematopoiesis explain unexplained anemia?", Blood, 135, pp.1078~1080 (2020)
90. Ogawa, S., "Clonal hematopoiesis in acquired aplastic anemia", Blood, 128, pp.337~347 (2016)
91. Xu, J., "Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis", Dev. Cell, 23, pp.796~811 (2012)
92. Xiang, G., "An integrative view of the regulatory and transcriptional land scapes in mouse hematopoiesis", Genome Res, 30, pp.472~484 (2020)
93. Xie, X., "Single-cell transcriptomic landscape of human blood cells", Natl Sci. Rev, 8, pp.nwaa180~ (2021)
94. Wagenblast, E., "Functional profiling of single CRISPR", Cas9-edited human long-term hematopoietic stem cells, 2019, pp.10, 1~11
95. Lucas, D., "Utility of CRISPR", Cas9 systems in hematology research, 2017, pp.54, 1~3
96. Morris, J. A., "Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens", Science, 380, pp.1~44 (2023)
97. Miles, L. A., "Single-cell mutation analysis of clonal evolution in myeloid malignancies", Nature, 587, pp.477~482 (2020)
98. Sankaran, V. G., "Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A", Science, 322, pp.1839~1842 (2008)
99. Frangoul, H., "CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia", N. Engl. J. Med, 384, pp.252~260 (2021)
100. Esrick, E. B., "Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease", N. Engl. J. Med, 384, pp.205~215 (2021)

관련 논문AI추천